ErbB4 as a potential molecular target in the treatment of esophageal squamous cell cancers

Ke Zhao1, Bao-Jun Chen1, Zhi-Guo Chen1

  • 1Department of Thoracic Surgery, The Central Hospital of Wuhan, Jiang'an District, Wuhan, Hubei 430014, China.

Thescientificworldjournal
|December 25, 2014
PubMed

Insights

MicroRNA-140-5p effectively targets ErbB4, a receptor tyrosine kinase, in esophageal cancer cells. This finding suggests miRNA-140-5p as a potential therapeutic target for esophageal squamous cell carcinoma (ESCC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • ErbB4, a receptor tyrosine kinase, is overexpressed in various cancers, but its role in esophageal cancer remains unclear.
  • Understanding the regulation of ErbB4 is crucial for developing targeted therapies for esophageal cancer.

Purpose of the Study:

  • To investigate if microRNA-140-5p (miRNA-140-5p) can target and regulate ErbB4 expression at the transcriptional level.
  • To evaluate the biological effects of miRNA-140-5p on esophageal cancer cell behavior.

Main Methods:

  • Western blotting and luciferase assays were used to assess ErbB4 expression.
  • Cell proliferation, apoptosis, and invasion were studied using MTT, flow cytometry, and transwell assays.

Main Results:

  • miRNA-140-5p significantly downregulated ErbB4 expression in EC9706 and TE-1A esophageal cancer cell lines.
  • Transfection with miRNA-140-5p suppressed cell proliferation, enhanced apoptosis, and reduced DNA synthesis and caspase 3/7 activity.
  • miRNA-140-5p markedly inhibited cancer cell invasion and migration.

Conclusions:

  • miRNA-140-5p acts as a regulator of ErbB4 in esophageal squamous cell carcinoma (ESCC) cells.
  • miRNA-140-5p demonstrates potential as a molecular target for treating ErbB4-overexpressing esophageal cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.4K